C. W. Shepard, L. Finelli, and M. J. Alter, Global epidemiology of hepatitis C virus infection, The Lancet Infectious Diseases, vol.5, issue.9, pp.558-67, 2005.
DOI : 10.1016/S1473-3099(05)70216-4

J. M. Pawlotsky, Hepatitis: HCV variability, the immune system and resistance to antiviral drugs, Nature Reviews Gastroenterology & Hepatology, vol.360, issue.7, pp.383-385, 2009.
DOI : 10.1038/nrgastro.2009.102

D. Moradpour, V. Brass, R. Gosert, B. Wolk, and H. E. Blum, Hepatitis C: molecular virology and antiviral targets, Trends in Molecular Medicine, vol.8, issue.10, pp.476-482, 2002.
DOI : 10.1016/S1471-4914(02)02395-X

F. Penin, Structural biology of hepatitis C virus, Clinics in Liver Disease, vol.7, issue.1, pp.1-21, 2003.
DOI : 10.1016/S1089-3261(02)00066-1
URL : https://hal.archives-ouvertes.fr/hal-00313003

L. B. Dustin and C. M. Rice, Flying Under the Radar: The Immunobiology of Hepatitis C, Annual Review of Immunology, vol.25, issue.1, pp.71-99, 2007.
DOI : 10.1146/annurev.immunol.25.022106.141602

B. Rehermann and M. Nascimbeni, Immunology of hepatitis B virus and hepatitis C virus infection, Nature Reviews Immunology, vol.24, issue.3, pp.215-229, 2005.
DOI : 10.1172/JCI200318509

S. Gurunathan, M. D. Klinman, and A. R. Seder, DNA Vaccines: Immunology, Application, and Optimization, Annual Review of Immunology, vol.18, issue.1, pp.927-974, 2000.
DOI : 10.1146/annurev.immunol.18.1.927

P. Sarobe, J. J. Lasarte, N. Casares, C. A. Lopez-diaz-de, E. Baixeras et al., Abnormal Priming of CD4+ T Cells by Dendritic Cells Expressing Hepatitis C Virus Core and E1 Proteins, Journal of Virology, vol.76, issue.10, pp.76-5062, 2002.
DOI : 10.1128/JVI.76.10.5062-5070.2002

L. Shi, S. Liu, G. Fan, L. Sheng, H. Ren et al., Effective Induction of Type 1 Cytotoxic T Cell Responses in Mice with DNA Vaccine Encoding Two Hepatitis C Virus Cytotoxic T Lymphocyte Epitopes, Viral Immunology, vol.19, issue.4, pp.702-711, 2006.
DOI : 10.1089/vim.2006.19.702

A. Sette, B. Livingston, D. Mckinney, E. Appella, J. Fikes et al., The Development of Multi-epitope Vaccines: Epitope Identification, Vaccine Design and Clinical Evaluation, Biologicals, vol.29, issue.3-4, pp.271-276, 2001.
DOI : 10.1006/biol.2001.0297

A. Suhrbier, Polytope vaccines for the codelivery of multiple CD8T-cell epitopes, Expert Review of Vaccines, vol.1, issue.2, pp.207-213, 2002.
DOI : 10.1586/14760584.1.2.207

L. Chen, T. Gao, N. Yang, J. Huang, Y. Chen et al., Immunization with a Synthetic Multiepitope Antigen Induces Humoral and Cellular Immune Responses to Hepatitis C Virus in Mice, Viral Immunology, vol.20, issue.1, pp.170-179, 2007.
DOI : 10.1089/vim.2006.0067

P. Martin, B. Simon, Y. C. Lone, L. Chatel, R. Barry et al., A vector-based minigene vaccine approach results in strong induction of T-cell responses specific of hepatitis C virus, Vaccine, vol.26, issue.20, pp.2471-2481, 2008.
DOI : 10.1016/j.vaccine.2008.03.028

R. A. Thomson, S. L. Ffrench, H. Elliott, F. A. Firat, A. Lemonnier et al., Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA-A2 HIV CD8+ cytotoxic T-cell epitopes, J. Virol, pp.73-5320, 1999.

J. N. Radcliffe, J. S. Roddick, P. S. Friedmann, F. K. Stevenson, and S. M. Thirdborough, Prime-Boost with Alternating DNA Vaccines Designed to Engage Different Antigen Presentation Pathways Generates High Frequencies of Peptide-Specific CD8+ T Cells, The Journal of Immunology, vol.177, issue.10, pp.6626-6633, 2006.
DOI : 10.4049/jimmunol.177.10.6626

H. Jin, Y. Kang, C. Xiao, K. Zhu, Y. Ma et al., DNA-prime followed by protein-boost
DOI : 10.1089/vim.2005.18.539

P. Sarobe, E. Huarte, J. J. Lasarte, L. De-cerio, N. Garcia et al., Characterization of an immunologically conserved epitope from hepatitis C virus E2 glycoprotein recognized by HLA-A2 restricted cytotoxic T lymphocytes, Journal of Hepatology, vol.34, issue.2, pp.34-321, 2001.
DOI : 10.1016/S0168-8278(00)00018-0

R. Thimme, D. Oldach, K. M. Chang, C. Steiger, S. C. Ray et al., Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection, The Journal of Experimental Medicine, vol.43, issue.10, pp.1395-1406, 2001.
DOI : 10.1126/science.284.5415.825

F. Roohvand, M. R. Aghasadeghi, S. M. Sadat, A. Budkowska, and A. R. Khabiri, HCV core protein immunization with Montanide/CpG elicits strong Th1/Th2 and long-lived CTL responses, Biochemical and Biophysical Research Communications, vol.354, issue.3, pp.354-641, 2007.
DOI : 10.1016/j.bbrc.2006.12.232

K. Shinoda, K. Q. Xin, N. Jounai, Y. Kojima, Y. Tamura et al., Polygene DNA vaccine induces a high level of protective effect against HIV-vaccinia virus challenge in mice, Vaccine, vol.22, issue.27-28, pp.3676-3690, 2004.
DOI : 10.1016/j.vaccine.2004.03.015

E. Sprecher and Y. Becker, Herpes simplex virus type 1 pathogenicity in footpad and ear skin of mice depends on langerhans cell density, mouse genetics, and virus strain, J. Virol, pp.61-2515, 1987.

M. Jazayeri, H. Soleimanjahi, F. Fotouhi, and N. Pakravan, Comparison of intramuscular and footpad subcutaneous immunization with DNA vaccine encoding HSV-gD2 in mice, Comparative Immunology, Microbiology and Infectious Diseases, vol.32, issue.5, pp.32-453, 2009.
DOI : 10.1016/j.cimid.2008.05.002

J. S. Boyle, C. Koniaras, and A. M. Lew, Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization, International Immunology, vol.9, issue.12, pp.1897-1906, 1997.
DOI : 10.1093/intimm/9.12.1897

A. Baez-astua, E. Herraez-hernandez, N. Garbi, H. A. Pasolli, V. Juarez et al., Cid-Arregui, Low-dose adenovirus vaccine encoding chimeric hepatitis B virus surface antigen-human papillomavirus type-16 E7 proteins induces enhanced E7- specific antibody and cytotoxic T-cell responses, J. Virol, pp.79-12807, 2005.

J. Jin, J. Yang, J. Liu, Y. Kong, Y. Wang et al., DNA immunization with fusion genes encoding different regions of hepatitis C virus E2 fused to the gene for hepatitis B surface antigen elicits immune responses to both HCV and HBV, World Journal of Gastroenterology, vol.8, issue.3, pp.505-510, 2002.
DOI : 10.3748/wjg.v8.i3.505

H. J. Netter, T. B. Macnaughton, W. P. Woo, and R. Tindle, Antigenicity and Immunogenicity of Novel Chimeric Hepatitis B Surface Antigen Particles with Exposed Hepatitis C Virus Epitopes, Journal of Virology, vol.75, issue.5, pp.75-2130, 2001.
DOI : 10.1128/JVI.75.5.2130-2141.2001

. Shih, Induction of multispecific Th-1 type immune response against HCV in mice by protein immunization using CpG and Montanide ISA 720 as adjuvants, Vaccine, vol.26, pp.5527-5534, 2008.

R. M. Welsh, J. M. Mcnally, M. A. Brehm, and L. K. Selin, Consequences of Cross-Reactive and Bystander CTL Responses during Viral Infections, Virology, vol.270, issue.1, pp.4-8, 2000.
DOI : 10.1006/viro.2000.0278